AFYREN NEOXY Achieves First Significant Revenue with €1M in 2025 Sales

  • AFYREN NEOXY generated €1M in revenue from 400 tons of bio-based acids and fertilizers in 2025, with €0.5M invoiced by year-end.
  • Production was paused twice in H2 2025 to address operational bottlenecks but rebounded strongly in Q4, producing ~200 tons.
  • All produced volumes were sold to nine customers, including five from existing contracts and four new clients across flavors, fragrances, and life sciences.
  • The company secured a competitive tender for 2026 with a leading player in the flavors and fragrances sector.

AFYREN's transition to continuous industrial-scale production validates its fermentation technology, positioning it as a key player in the bio-based chemicals sector. The company's ability to secure outlets for all produced volumes underscores growing demand for sustainable alternatives in strategic sectors like flavors, fragrances, and life sciences. With €165M in contracted volumes and expansion projects in Thailand and the Americas, AFYREN is poised to capitalize on the broader shift toward decarbonization in manufacturing.

Production Scaling
Whether AFYREN can sustain the pace of productivity improvements to meet accelerated revenue growth expectations in 2026.
Market Expansion
How the company's ability to secure high-value derivative product contracts will impact its commercial expansion strategy.
Operational Stability
The impact of voluntary production shutdowns on long-term operational efficiency and customer delivery commitments.